Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular tumour boards — current and future considerations for precision oncology
Apostolia M. Tsimberidou, Michael Kahle, Henry Hiep Vo, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 12, pp. 843-863
Closed Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

Copenhagen Prospective Personalized Oncology (CoPPO) – Impact of comprehensive genomic profiling in more than 2000 patients in a Phase I setting
Laïla Belcaid, Martin Højgaard, Ida Elisabeth Viller Tuxen, et al.
Annals of Oncology (2025)
Closed Access
Healthcare Security Challenges Leveraging Generative AI to Transform Cybersecurity
Ghalib Nadeem, Ab Dulmalik Khaliq, J. Ahmed, et al.
IGI Global eBooks (2025), pp. 205-250
Closed Access
Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives
Valentino Martelli, Joana Vidal, Sílvia Salvans, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1461-1461
Open Access
The Role of Algorithms in Molecular Tumour Boards—Managing the Gap Between Research and Clinic in Precision Medicine
D Hofmann, Elena Esposito
Sociology of Health & Illness (2025) Vol. 47, Iss. 4
Open Access
Real-World Data: Implementation and Outcomes of Next-Generation Sequencing in the MENA Region
Rami Mahfouz, Reine Abou Zeidane, Tasnim Diab, et al.
Diagnostics (2025) Vol. 15, Iss. 10, pp. 1183-1183
Open Access
Time‐Controlled Authentication Strategies for Molecular Information Transfer
Minghao Hu, Mengyao Yang, Xianzhi Cheng, et al.
Small (2024)
Closed Access | Times Cited: 3
Histology agnosticism: Infra-molecularizing disease?
Jonah Campbell, Alberto Cambrosio, Mark Basik
Studies in History and Philosophy of Science Part A (2024) Vol. 104, pp. 14-22
Open Access | Times Cited: 2
What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland
Ina Pretzell, Alexander Desuki, Annalen Bleckmann, et al.
Oncology Research and Treatment (2024) Vol. 47, Iss. 9, pp. 410-419
Closed Access | Times Cited: 2
The current (and possibly future) role of opioid analgesia in lung cancer surgery
Alessia Pedoto, Gregory W. Fischer, Joshua S. Mincer
Best Practice & Research Clinical Anaesthesiology (2024) Vol. 38, Iss. 1, pp. 74-80
Closed Access | Times Cited: 2
Application of comprehensive molecular genetic profiling in precision cancer medicine, Hungarian experiences
Erika Tóth, Zsófia Kürönya, Edina Soós, et al.
Acta Oncologica (2024) Vol. 63, pp. 433-440
Open Access | Times Cited: 2
Biomarker Multiplexing with Rational Design of Nucleic Acid Probe Complex
Yu Zhao, Hui Xin, Chunyan Wang
Analysis & Sensing (2024) Vol. 4, Iss. 5
Closed Access | Times Cited: 2
Dynamic convergence of autism disorder risk genes across neurodevelopment
Meilín Fernández García, Kayla G. Townsley, April Pruitt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Clinical bioinformatics desiderata for molecular tumor boards
Matteo Pallocca, Martina Betti, Sara Baldinelli, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 2
Molecular tumor board in patients with metastatic breast cancer
Luca Boscolo Bielo, Elena Guerini‐Rocco, Edoardo Crimini, et al.
Breast Cancer Research and Treatment (2024) Vol. 210, Iss. 1, pp. 45-55
Closed Access | Times Cited: 2
CRISPR/RNA Aptamer System Activated by an AND Logic Gate for Biomarker-Driven Theranostics
Qiqi Yang, Mingjie Dong, Jing Xu, et al.
Journal of the American Chemical Society (2024)
Closed Access | Times Cited: 2
Precise Therapeutic Targeting of DistinctNRXN1+/-Mutations
Michael B. Fernando, Yu Fan, Yanchun Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Molecular Tumor Boards: On the evolution of species
Patrizio Giacomini, Gennaro Ciliberto
European Journal of Cancer (2024) Vol. 201, pp. 113910-113910
Closed Access | Times Cited: 1
Personalisierte Medizin in der Onkologie
Alisa Martina Lörsch, Johannes Jung, Sebastian Lange, et al.
Deleted Journal (2024) Vol. 45, Iss. 3, pp. 180-189
Closed Access | Times Cited: 1
Liquid profiling for patients with advanced cancer is ready for clinical integration
Samantha O. Hasenleithner, Ellen Heitzer
memo - Magazine of European Medical Oncology (2024) Vol. 17, Iss. 3, pp. 182-189
Open Access | Times Cited: 1
Expert-Guided Large Language Models for Clinical Decision Support in Precision Oncology
Jacqueline Lammert, Tobias Dreyer, Sonja Mathes, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
The anti-tumor effects of main component (benzethonium chloride) of butorphanol tartrate injection in non-small cell lung cancer
Honglei Tao, Lei Li, Huiling Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit
Angela Espósito, Edoardo Crimini, Carmen Criscitiello, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4252-4252
Open Access | Times Cited: 1
Molekulare Tumorboards
Johannes Jung, Linda Gräßel, Melanie Boerries, et al.
Forum (2024) Vol. 39, Iss. 1, pp. 33-37
Closed Access | Times Cited: 1
Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study
Andriani Charpidou, Maria Mani, Eleni Kokkotou, et al.
Anticancer Research (2024) Vol. 44, Iss. 5, pp. 2063-2072
Open Access | Times Cited: 1
Personalised Drug Identifier for Cancer Treatment with Transformers using Auxiliary Information
Aishwarya Jayagopal, Hansheng Xue, Ziyang He, et al.
Proceedings of the 28th ACM SIGKDD Conference on Knowledge Discovery and Data Mining (2024), pp. 5138-5149
Open Access | Times Cited: 1

Scroll to top